(BXP) Boston Properties - Ratings and Ratios
Office, Towers, Campuses, Labs, Hotels
EPS (Earnings per Share)
Revenue
Dividends
| Dividend Yield | 4.89% |
| Yield on Cost 5y | 4.84% |
| Yield CAGR 5y | -3.78% |
| Payout Consistency | 92.4% |
| Payout Ratio | 2.6% |
| Risk via 5d forecast | |
|---|---|
| Volatility | 26.0% |
| Value at Risk 5%th | 42.7% |
| Relative Tail Risk | -0.21% |
| Reward TTM | |
|---|---|
| Sharpe Ratio | 0.09 |
| Alpha | -16.16 |
| CAGR/Max DD | 0.11 |
| Character TTM | |
|---|---|
| Hurst Exponent | 0.461 |
| Beta | 0.889 |
| Beta Downside | 0.870 |
| Drawdowns 3y | |
|---|---|
| Max DD | 39.56% |
| Mean DD | 16.60% |
| Median DD | 16.46% |
Description: BXP Boston Properties January 04, 2026
Boston Properties Inc. (NYSE:BXP) is the largest publicly-traded REIT focused on premium office spaces in the United States, with a concentrated presence in six “gateway” markets-Boston, Los Angeles, New York, San Francisco, Seattle, and Washington, DC. The company operates as a fully integrated developer, owner, and manager, and as of September 30 2025 its portfolio (including joint-venture assets) comprised roughly 54.6 million sq ft across 187 properties, of which eight were under construction or redevelopment.
Recent performance metrics (FY 2024, disclosed in the most recent 10-K) show an adjusted funds-from-operations (FFO) of about $5.10 per share, a dividend yield near 5.3 %, and an occupancy rate of roughly 95 % across its core markets. Leverage remains moderate, with a debt-to-EBITDA ratio of ~5.5×, reflecting the REIT’s disciplined capital structure.
The office-sector outlook is heavily influenced by three macro drivers: (1) the trajectory of U.S. interest rates, which affect both financing costs and cap-rate compression; (2) the pace of corporate hybrid-work adoption, which determines demand for high-quality, centrally located office inventory; and (3) regional economic growth differentials, with the six gateway cities historically delivering higher GDP per-capita growth than the national average, supporting rent-growth potential for premium assets.
For a deeper quantitative assessment, you may find the ValueRay platform useful for benchmarking BXP’s valuation against peers.
Piotroski VR‑10 (Strict, 0-10) 3.0
| Net Income (-200.4m TTM) > 0 and > 6% of Revenue (6% = 207.8m TTM) |
| FCFTA 0.03 (>2.0%) and ΔFCFTA -0.58pp (YES ≥ +1.0pp, WARN ≥ +0.5pp) |
| NWC/Revenue 35.88% (prev 8.36%; Δ 27.52pp) (YES ≤20% & Δ≤-1pp; WARN ≤25% & Δ≤0 oder ≤40% & Δ≤-3pp) |
| CFO/TA 0.05 (>3.0%) and CFO 1.22b > Net Income -200.4m (YES >=105%, WARN >=100%) |
| Net Debt (16.49b) to EBITDA (1.42b) ratio: 11.59 <= 3.0 (WARN <= 3.5) |
| Current Ratio 1.84 (target 1.5–3.0; WARN 1.2–<1.5 or >3.0–5.0; CFO/TA gate active) |
| Outstanding Shares last Quarter (158.3m) change vs 12m ago 0.08% (target <= -2.0% for YES) |
| Gross Margin 60.84% (prev 48.24%; Δ 12.60pp) >=18% & Δ>=+0.5pp (WARN >=15% & Δ>=0) |
| Asset Turnover 13.22% (prev 12.79%; Δ 0.43pp) >=50% & Δ>=+2pp (WARN >=35% & Δ>=0) |
| Interest Coverage Ratio 0.77 (EBITDA TTM 1.42b / Interest Expense TTM 660.9m) >= 6 (WARN >= 3) |
Altman Z'' 0.11
| (A) 0.05 = (Total Current Assets 2.72b - Total Current Liabilities 1.48b) / Total Assets 26.00b |
| (B) -0.07 = Retained Earnings (Balance) -1.81b / Total Assets 26.00b |
| (C) 0.02 = EBIT TTM 510.4m / Avg Total Assets 26.20b |
| (D) -0.10 = Book Value of Equity -1.83b / Total Liabilities 18.48b |
| Total Rating: 0.11 = (6.56 * A) + (3.26 * B) + (6.72 * C) + (1.05 * D) |
ValueRay F-Score (Strict, 0-100) 50.58
| 1. Piotroski 3.0pt |
| 2. FCF Yield 2.33% |
| 3. FCF Margin 18.93% |
| 4. Debt/Equity 3.46 |
| 5. Debt/Ebitda 11.59 |
| 6. ROIC - WACC (= -3.39)% |
| 7. RoE -3.82% |
| 8. Rev. Trend 96.81% |
| 9. EPS Trend -35.49% |
What is the price of BXP shares?
Over the past week, the price has changed by +1.33%, over one month by -4.11%, over three months by -2.03% and over the past year by +2.94%.
Is BXP a buy, sell or hold?
- Strong Buy: 6
- Buy: 3
- Hold: 11
- Sell: 1
- Strong Sell: 1
What are the forecasts/targets for the BXP price?
| Issuer | Target | Up/Down from current |
|---|---|---|
| Wallstreet Target Price | 78.8 | 15.9% |
| Analysts Target Price | 78.8 | 15.9% |
| ValueRay Target Price | 70.5 | 3.6% |
BXP Fundamental Data Overview January 09, 2026
P/S = 3.4155
P/B = 2.0927
P/EG = 0.2808
Beta = 1.028
Revenue TTM = 3.46b USD
EBIT TTM = 510.4m USD
EBITDA TTM = 1.42b USD
Long Term Debt = 15.85b USD (from longTermDebt, last quarter)
Short Term Debt = 750.0m USD (from shortTermDebt, last quarter)
Debt = 17.35b USD (from shortLongTermDebtTotal, last quarter)
Net Debt = 16.49b USD (from netDebt column, last quarter)
Enterprise Value = 28.18b USD (11.70b + Debt 17.35b - CCE 861.1m)
Interest Coverage Ratio = 0.77 (Ebit TTM 510.4m / Interest Expense TTM 660.9m)
EV/FCF = 42.99x (Enterprise Value 28.18b / FCF TTM 655.6m)
FCF Yield = 2.33% (FCF TTM 655.6m / Enterprise Value 28.18b)
FCF Margin = 18.93% (FCF TTM 655.6m / Revenue TTM 3.46b)
Net Margin = -5.79% (Net Income TTM -200.4m / Revenue TTM 3.46b)
Gross Margin = 60.84% ((Revenue TTM 3.46b - Cost of Revenue TTM 1.36b) / Revenue TTM)
Gross Margin QoQ = 60.83% (prev 60.69%)
Tobins Q-Ratio = 1.08 (Enterprise Value 28.18b / Total Assets 26.00b)
Interest Expense / Debt = 0.95% (Interest Expense 164.3m / Debt 17.35b)
Taxrate = 83.05% (69.9m / 84.2m)
NOPAT = 86.5m (EBIT 510.4m * (1 - 83.05%))
Current Ratio = 1.84 (Total Current Assets 2.72b / Total Current Liabilities 1.48b)
Debt / Equity = 3.46 (Debt 17.35b / totalStockholderEquity, last quarter 5.01b)
Debt / EBITDA = 11.59 (Net Debt 16.49b / EBITDA 1.42b)
Debt / FCF = 25.15 (Net Debt 16.49b / FCF TTM 655.6m)
Total Stockholder Equity = 5.25b (last 4 quarters mean from totalStockholderEquity)
RoA = -0.76% (Net Income -200.4m / Total Assets 26.00b)
RoE = -3.82% (Net Income TTM -200.4m / Total Stockholder Equity 5.25b)
RoCE = 2.42% (EBIT 510.4m / Capital Employed (Equity 5.25b + L.T.Debt 15.85b))
RoIC = 0.41% (NOPAT 86.5m / Invested Capital 21.33b)
WACC = 3.80% (E(11.70b)/V(29.05b) * Re(9.19%) + D(17.35b)/V(29.05b) * Rd(0.95%) * (1-Tc(0.83)))
Discount Rate = 9.19% (= CAPM, Blume Beta Adj.)
Shares Correlation 3-Years: 100.0 | Cagr: 0.34%
[DCF Debug] Terminal Value 86.30% ; FCFF base≈721.2m ; Y1≈718.3m ; Y5≈754.4m
Fair Price DCF = 38.03 (EV 22.51b - Net Debt 16.49b = Equity 6.03b / Shares 158.5m; r=5.90% [WACC]; 5y FCF grow -1.05% → 2.90% )
EPS Correlation: -35.49 | EPS CAGR: -29.23% | SUE: -1.48 | # QB: 0
Revenue Correlation: 96.81 | Revenue CAGR: 4.80% | SUE: 1.90 | # QB: 15
EPS next Quarter (2026-03-31): EPS=0.34 | Chg30d=-0.020 | Revisions Net=-1 | Analysts=1
EPS next Year (2026-12-31): EPS=2.05 | Chg30d=+0.000 | Revisions Net=-1 | Growth EPS=-5.0% | Growth Revenue=+1.9%
Additional Sources for BXP Stock
Tweets: X | Stocktwits
Fund Manager Positions: Dataroma | Stockcircle